Patents by Inventor Gregory C. Rigdon

Gregory C. Rigdon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100056637
    Abstract: The present invention provides methods of treating or preventing asthma or an inflammatory disease. In one embodiment, the invention provides compounds and formulations for the treatment of asthma or an inflammatory disease.
    Type: Application
    Filed: September 18, 2009
    Publication date: March 4, 2010
    Applicant: Icagen, Inc.
    Inventors: Neil A. Castle, Gregory C. Rigdon, Douglas S. Krafte, Jeffrey L. Krajewski
  • Publication number: 20090036538
    Abstract: The use of novel inhibitors of potassium flux is disclosed for the treatment of inflammatory processes, such as multiple sclerosis, insulin-dependent (type I) diabetes mellitus, rheumatoid arthritis, peripheral neuritis and pulmonary hypertension. The compounds are also of use in treating and preventing stroke. These inhibitors have a high specificity for the IK1 channel and greater stability relative to non-fluorine substituted homologues.
    Type: Application
    Filed: September 19, 2008
    Publication date: February 5, 2009
    Applicant: Icagen, Inc.
    Inventors: Neil A. Castle, Gregory C. Rigdon, Douglas S. Krafte
  • Publication number: 20040029771
    Abstract: This invention relates to the use of compounds able to decrease potassium ion flow through intermediate conductance calcium activated potassium channels for treatment of diseases related to increased intraocular pressure modulated by intermediate conductance calcium activated potassium channels.
    Type: Application
    Filed: February 28, 2003
    Publication date: February 12, 2004
    Applicant: Icagen, Inc.
    Inventors: Gregory C. Rigdon, Jonathan W. Stocker, Grant A. McNaughton-Smith